Revolutionary Discovery for Drug Development

Today, the majority of drugs and pharmaceuticals on the market that treat human disease are designed to target a specific protein. But University of North Carolina at Chapel Hill startup, Ribometrix, has a very different, revolutionary approach to new drug discovery that’s proving to be a breakthrough in the industry.

Ribometrix’s novel approach has the potential to improve millions of lives by offering new treatments for a range of diseases, ranging from cancer, neurological disorders, immunological diseases, and rare diseases such as Huntington’s Disease.

“The company was made possible with technology developed at UNC, with support from the UNC ecosystem. The initial ideas and innovation came from the academic side, but we were able to transfer this knowledge into something tangible and entrepreneurial for the greater good,” said Katie Warner, co-founder and director of research at Ribometrix.

Read the complete Carolina Story from Innovate Carolina…


Related Stories

Flowing Together

Attracting expertise: A win for Carolina, a win for research

Archaeological Dig in Galilee Uncovers Mosaics